Search - tctmd.com

Displaying 461 - 480 of 485

Sort: Relevancy | Date

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

Presentation

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Presenter: Davide Capodanno

July 23, 2014

Presentation CIT 2014

Science Behind Bioresorbable Vascular Scaffolds

Presenter: Renu Virmani

March 20, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation

Bioresorbable Vascular Scaffolds in Acute STEMI

Presenter: V. Ko?ka

January 21, 2014

Presentation

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Presenter: Richard J. Rapoza

December 02, 2013

Presentation

Feasibility And Early Safety And Efficacy Outcomes Of Patients Undergoing Bioresorbable Vascular Scaffolds Implantation: The GHOST Registry – An Interim Report From The First 171 Patients Enrolled

Presenter: Corrado Tamburino

December 01, 2013

Presentation TCT 2013

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Presenter: Stephan Windecker

October 31, 2013

Presentation TCT 2013

Case 2: How to Overlap Bioresorbable Scaffolds

Presenter: Jose Costa Jr

October 31, 2013

Presentation TCT 2013

Tips and Tricks to Deploy Bioresorbable Scaffolds

Presenter: Alexandre Abizaid

October 31, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Are There "Special" Device Approval Considerations (Preclinical and Clinical) for Bioresorbable vs. Metallic Scaffolds?

Presenter: Melissa Torres

October 30, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds

Presenter: Robert-Jan van Geuns

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Presenter: Vladimir Dzavik

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

Presenter: Jochen W?hrle

October 28, 2013

Advertisement

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

GHOST-EU Registry: PCI With Everolimus-Eluting Bioresorbable Vascular Scaffolds in Routine Clinical Practice

Science Behind Bioresorbable Vascular Scaffolds

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Bioresorbable Vascular Scaffolds in Acute STEMI

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Feasibility And Early Safety And Efficacy Outcomes Of Patients Undergoing Bioresorbable Vascular Scaffolds Implantation: The GHOST Registry – An Interim Report From The First 171 Patients Enrolled

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Case 2: How to Overlap Bioresorbable Scaffolds

Tips and Tricks to Deploy Bioresorbable Scaffolds

Bioresorbable Vascular Scaffolds and Drug-Eluting Balloons: Which Subsets Meaningfully Benefit Beyond Metallic DES?

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Are There "Special" Device Approval Considerations (Preclinical and Clinical) for Bioresorbable vs. Metallic Scaffolds?

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Do I Really Need Bioresorbable Scaffolds in Germany?

Bioresorbable Vascular Scaffolds

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Do I Really Need Bioresorbable Scaffolds in the United States?

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content